[New perspectives of preventive pharmacotherapy in metabolic syndrome].
Ivleva
A Ia
AIa
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D001565:Benzoates / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007328:Insulin / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism; D024821:Metabolic Syndrome / Q000150:complications / Q000517:prevention & control*; D000077333:Telmisartan
D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D007328:Insulin; D008074:Lipoproteins; D000077333:Telmisartan